临床儿科杂志 ›› 2019, Vol. 37 ›› Issue (11): 847-.doi: 10.3969/j.issn.1000-3606.2019.11.012

• 综合报道 • 上一篇    下一篇

AHDC1 基因突变致 Xia-Gibbs 综合征 1 例报告并文献复习

杨书婷,李梅,贾春颖,冉艳萍, 吴霞   

  1. 重庆医科大学附属儿童医院神经内科、儿童发育疾病研究教育部重点实验室、儿童发育重大疾病国家国 际科技合作基地、儿科学重庆市重点实验室(重庆 400014)
  • 出版日期:2019-11-15 发布日期:2020-02-03

Xia-Gibbs syndrome in a child caused by a de novo AHDC1 mutation and literature review

YANG Shuting, LI Mei, JIA Chunying, RAN Yanping, WU Xia   

  1. 1.Department of Cardiology, 2.Department of Ultrasound, Hunan Children’s Hospital, Changsha 410007, Hunan, China
  • Online:2019-11-15 Published:2020-02-03

摘要: 目的 探讨AHDC1基因突变致Xia-Gibbs综合征的临床表现、基因变异特点。方法 回顾分析2018年12月 接诊的1例AHDC1基因突变致Xia-Gibbs综合征患儿的临床资料,并结合文献分析Xia-Gibbs综合征患儿的临床表现、基 因突变特点。结果 男性患儿, 5岁7月,以全面发育落后、面容特殊,耳位低,拇指内收为主要表现;头颅CT示双侧小脑 半球后外方脑外间隙增宽、蛛网膜囊肿。学龄前儿童韦克斯勒氏智能测试提示智商重度低下。全外显子检测发现AHDC1 基因新发剪切突变c.3185_c.3186delCA,导致蛋白编码提前终止(p.T1062Sfs*63),确诊为Xia-Gibbs综合征。检索万方 数据库,检出中文文献1篇;检索PubMed及Medline,检出英文文献16篇;合并该患儿共35例Xia-Gibbs综合征患儿,其 中34例为AHDC1基因新发突变, 1例为包含AHDC1基因在内的染色体微缺失所致。结论 Xia-Gibbs综合征是由AHDC1 基因新发突变所致神经系统疾病,其突变位点及临床表现的特异性目前尚无定论,二者的相关性有待进一步研究。

关键词: Xia-Gibbs综合征,  AHDC1基因突变,  全外显子测序,  儿童

Abstract:  Objective To explore the safety and prognosis of interventional therapy for congenital heart disease (CHD) complicated with left ventricular non-compaction (LVNC) in children. Methods The clinical data of congenital heart disease complicated with myocardial densification in children treated from January 2016 to October 2017 were retrospective analyzed. The changes of non-compacted layer/compacted layer (N/C) ratio and cardiac function parameters measured by color Doppler echocardiography before and after cardiac interventional therapy were compared. The complications were recorded. Results A total of 25 children (9 boys and 16 girls) were included and the median age was 1 year (0.14~8 years). There were 22 cases of patent ductus arteriosus, 2 cases of atrial septal defect and 1 case of ventricular septal defect. The differences in left ventricular end-diastolic diameter (LVEDD) -Z value and N/C ratio at pre-operation and at postoperative 1, 6 and 12 months were statistically significant (all P<0.05), with the lowest value at 12 months after operation. The LVNC basically disappeared during follow-up in 6 children. However, there was no significant difference in left ventricular ejection fraction (LVEF) between these time points (all P>0.05). There was no correlation among N/C ratio, LVEDD -z value and LVEF value before and at 1, 6 and 12 months after operation (all P>0.05). The median postoperative follow-up was 19 months (12-27 months), and no adverse cardiovascular events or arrhythmias occurred during the follow-up. Conclusions For Children with CHD complicated with LVNC, when no contraindications exist, interventional therapy is recommended to reduce left to right shunt and cardiac overload. It is conducive to left ventricular myocardial development and ventricular reverse remodeling.

Key words: congenital heart disease,  left ventricular non-compaction,  interventional therapy,  child